| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | PCDHB5 RYR2 CAPN13 BRAF UMODL1 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 GRM7 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 MAN1B1 | 4.87e-11 | 749 | 195 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.26e-09 | 14 | 195 | 6 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.72e-08 | 11 | 195 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.86e-08 | 21 | 195 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.71e-06 | 38 | 195 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.85e-05 | 37 | 195 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.85e-05 | 37 | 195 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.26e-05 | 38 | 195 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 8.36e-05 | 46 | 195 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | ABC-type peptide antigen transporter activity | 9.49e-05 | 2 | 195 | 2 | GO:0015433 | |
| GeneOntologyMolecularFunction | tapasin binding | 9.49e-05 | 2 | 195 | 2 | GO:0046980 | |
| GeneOntologyMolecularFunction | ABC-type peptide transporter activity | 5.62e-04 | 4 | 195 | 2 | GO:0015440 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 7.47e-04 | 152 | 195 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.06e-03 | 79 | 195 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ERVK-7 ERVK-10 ALKBH1 ERVK-11 SGIP1 CHD7 BTAF1 ERVK-8 | 1.13e-03 | 262 | 195 | 9 | GO:0140097 |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.17e-03 | 120 | 195 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP6V1A ABCA4 DHX38 ATP8B1 BCS1L HSPA1L TAP1 TAP2 HSPA6 HSPA7 CHD7 BTAF1 | 1.37e-03 | 441 | 195 | 12 | GO:0016887 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 1.03e-21 | 187 | 195 | 25 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 PCDHB5 ITGA3 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 ADGRL1 PCDHB16 CELSR3 PCDHGB4 TENM1 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 2.06e-19 | 313 | 195 | 28 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CEACAM5 RC3H1 PCDHB5 ITGA3 ITGAD TUBB1 GLI3 PCDHB1 FLNA PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 LAMA3 ADGRL1 PCDHB16 CELSR3 PDLIM1 PCDHGB4 TENM1 DCHS1 PARD3 PCDHGC3 PCDHGA8 CDH7 | 3.07e-11 | 1077 | 195 | 36 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 3.40e-08 | 53 | 195 | 8 | GO:0016339 | |
| GeneOntologyBiologicalProcess | DNA integration | 8.68e-08 | 13 | 195 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell junction organization | RELN CEACAM5 PCDHB5 PLXND1 ITGA3 RYK NEDD4 PARD6B PTPN13 GPR158 VSTM5 BSN FLNA COL16A1 PCDHGC5 PCDHB14 PCDHB3 APC LAMA3 ADGRL1 PCDHB16 IGF1R DOCK7 DIXDC1 PARD3 PCDHGC3 CDH7 DCLK1 | 1.52e-07 | 974 | 195 | 28 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | RELN PCDHB5 PLXND1 RYK PARD6B PTPN13 VSTM5 BSN COL16A1 PCDHB14 PCDHB3 APC LAMA3 ADGRL1 PCDHB16 DOCK7 PARD3 CDH7 DCLK1 | 2.08e-06 | 569 | 195 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | synapse organization | RELN PCDHB5 PLXND1 ITGA3 RYK NEDD4 PTPN13 GPR158 VSTM5 BSN FLNA PCDHGC5 PCDHB14 PCDHB3 ADGRL1 PCDHB16 IGF1R DOCK7 DIXDC1 PCDHGC3 DCLK1 | 2.29e-06 | 685 | 195 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 5.83e-06 | 48 | 195 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | synapse assembly | RELN PCDHB5 PLXND1 RYK PTPN13 VSTM5 BSN PCDHB14 PCDHB3 ADGRL1 PCDHB16 DOCK7 DCLK1 | 7.91e-06 | 308 | 195 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | axon development | RELN PLXND1 RYK PARD6B BRAF GLI3 NOVA2 FLNA B4GAT1 APC LAMA3 GRM7 IGF1R CELSR3 DOCK7 DIXDC1 PARD3 DCLK1 | 4.08e-05 | 642 | 195 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron development | RELN ATP8B1 PLXND1 ITGA3 RYK TULP1 NEDD4 PARD6B MET ALKBH1 BRAF GLI3 DCLK2 NOVA2 FLNA RPGRIP1L B4GAT1 APC LAMA3 GRM7 PREX2 IGF1R CELSR3 DOCK7 TENM1 ATF1 DIXDC1 PARD3 DCLK1 TP73 | 4.86e-05 | 1463 | 195 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RELN PLXND1 RYK NEDD4 PARD6B MET BRAF GLI3 NOVA2 B4GAT1 APC LAMA3 PREX2 IGF1R CELSR3 DOCK7 DIXDC1 PARD3 DCLK1 | 9.27e-05 | 748 | 195 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | RELN PLXND1 RYK PARD6B BRAF GLI3 NOVA2 B4GAT1 APC LAMA3 IGF1R CELSR3 DOCK7 DIXDC1 PARD3 DCLK1 | 1.01e-04 | 566 | 195 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.36e-04 | 83 | 195 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RELN PLXND1 RYK NEDD4 PARD6B MET BRAF GLI3 NOVA2 B4GAT1 APC LAMA3 PREX2 IGF1R CELSR3 DOCK7 DIXDC1 PARD3 DCLK1 | 2.27e-04 | 802 | 195 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | serine import into mitochondrion | 2.65e-04 | 3 | 195 | 2 | GO:0140300 | |
| GeneOntologyBiologicalProcess | adaptive thermogenesis | 2.78e-04 | 176 | 195 | 8 | GO:1990845 | |
| GeneOntologyBiologicalProcess | myeloid progenitor cell differentiation | 2.80e-04 | 14 | 195 | 3 | GO:0002318 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN PLXND1 RYK NEDD4 PARD6B MET BRAF GLI3 NOVA2 B4GAT1 APC LAMA3 PREX2 IGF1R CELSR3 DOCK7 DIXDC1 PARD3 DCLK1 | 2.95e-04 | 819 | 195 | 19 | GO:0120039 |
| HumanPheno | Impairment in personality functioning | ATP6V1A RELN B4GALNT1 PPP1R12A ATP8B1 BCS1L TULP1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A SLC26A9 ADGRL1 CHD7 RFX7 GRM7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 4.17e-06 | 1141 | 50 | 26 | HP:0031466 |
| HumanPheno | Abnormal upper lip morphology | ATP6V1A PPP1R12A QRICH1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L DYRK1A APC CHD7 RFX7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 ANKRD17 MAN1B1 | 1.40e-05 | 980 | 50 | 23 | HP:0000177 |
| HumanPheno | Aplasia/Hypoplasia of the corpus callosum | ATP6V1A RELN PPP1R12A BRAF GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L B4GAT1 DYRK1A GRM7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 TP73 | 1.65e-05 | 772 | 50 | 20 | HP:0007370 |
| HumanPheno | Abnormally increased volition | ATP6V1A RELN PPP1R12A TULP1 UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 2.70e-05 | 869 | 50 | 21 | HP:5200263 |
| HumanPheno | Disinhibition | ATP6V1A RELN PPP1R12A TULP1 UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 MED25 DCHS1 ANKRD17 MAN1B1 | 3.23e-05 | 807 | 50 | 20 | HP:0000734 |
| HumanPheno | Inappropriate behavior | ATP6V1A RELN PPP1R12A TULP1 UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 MED25 DCHS1 ANKRD17 MAN1B1 | 3.23e-05 | 807 | 50 | 20 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | ATP6V1A RELN PPP1R12A TULP1 UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 MED25 DCHS1 ANKRD17 MAN1B1 | 3.23e-05 | 807 | 50 | 20 | HP:5200123 |
| HumanPheno | Social disinhibition | ATP6V1A RELN PPP1R12A TULP1 UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 MED25 DCHS1 ANKRD17 MAN1B1 | 3.23e-05 | 807 | 50 | 20 | HP:5200029 |
| HumanPheno | Abnormality of the palpebral fissures | ATP6V1A PPP1R12A QRICH1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA DYRK1A APC CHD7 RFX7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 3.29e-05 | 880 | 50 | 21 | HP:0008050 |
| HumanPheno | Slanting of the palpebral fissure | ATP6V1A PPP1R12A QRICH1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA DYRK1A APC CHD7 RFX7 IGF1R MED25 ANKRD17 MAN1B1 | 3.35e-05 | 739 | 50 | 19 | HP:0200006 |
| HumanPheno | Hydronephrosis | BRAF GLI3 FLNA B4GAT1 DYRK1A APC LAMA3 CHD7 RFX7 PIEZO2 MED25 | 3.61e-05 | 264 | 50 | 11 | HP:0000126 |
| HumanPheno | Recurrent maladaptive behavior | ATP6V1A RELN B4GALNT1 PPP1R12A BCS1L TULP1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A SLC26A9 ADGRL1 CHD7 RFX7 GRM7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 ANKRD17 MAN1B1 | 4.60e-05 | 1293 | 50 | 26 | HP:5200241 |
| HumanPheno | Radial head subluxation | 4.81e-05 | 8 | 50 | 3 | HP:0003048 | |
| HumanPheno | Anteverted nares | ATP6V1A QRICH1 BRAF GLI3 MED12L NOVA2 FLII RPGRIP1L DYRK1A APC RFX7 GRM7 PIEZO2 IGF1R MED25 DOCK7 | 4.95e-05 | 559 | 50 | 16 | HP:0000463 |
| HumanPheno | Upturned nose | ATP6V1A QRICH1 BRAF GLI3 MED12L NOVA2 FLII RPGRIP1L DYRK1A APC RFX7 GRM7 PIEZO2 IGF1R MED25 DOCK7 | 4.95e-05 | 559 | 50 | 16 | HP:0000427 |
| HumanPheno | Abnormal social development | ATP6V1A RELN PPP1R12A TULP1 UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 MED25 DOCK7 DCHS1 ANKRD17 MAN1B1 | 5.34e-05 | 908 | 50 | 21 | HP:0025732 |
| HumanPheno | Abnormal nasal tip morphology | ATP6V1A QRICH1 BRAF UBAP2L MED12L FLNA DYRK1A APC RFX7 IGF1R MED25 DOCK7 MAN1B1 | 5.92e-05 | 386 | 50 | 13 | HP:0000436 |
| HumanPheno | Abnormal external nose morphology | ATP6V1A QRICH1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L DYRK1A APC RFX7 GRM7 PIEZO2 IGF1R MED25 DOCK7 ANKRD17 MAN1B1 | 6.11e-05 | 916 | 50 | 21 | HP:0010938 |
| HumanPheno | Abnormal morphology of the nasal alae | ATP6V1A QRICH1 BRAF GLI3 MED12L NOVA2 FLII RPGRIP1L DYRK1A APC RFX7 GRM7 PIEZO2 IGF1R MED25 DOCK7 ANKRD17 | 6.78e-05 | 639 | 50 | 17 | HP:0000429 |
| HumanPheno | Abnormal nostril morphology | ATP6V1A QRICH1 BRAF GLI3 MED12L NOVA2 FLII RPGRIP1L DYRK1A APC RFX7 GRM7 PIEZO2 IGF1R MED25 DOCK7 | 7.01e-05 | 575 | 50 | 16 | HP:0005288 |
| HumanPheno | Dilatation of the renal pelvis | BRAF GLI3 FLNA B4GAT1 DYRK1A APC LAMA3 CHD7 RFX7 PIEZO2 MED25 | 8.55e-05 | 290 | 50 | 11 | HP:0010946 |
| HumanPheno | Visual acuity no light perception | 9.44e-05 | 2 | 50 | 2 | HP:0030553 | |
| HumanPheno | Thin corpus callosum | ATP6V1A RELN PPP1R12A BRAF GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L B4GAT1 DYRK1A GRM7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 TP73 | 9.46e-05 | 868 | 50 | 20 | HP:0033725 |
| HumanPheno | Abnormality of upper lip vermillion | QRICH1 UBAP2L MED12L KNL1 FLII DYRK1A APC RFX7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 9.64e-05 | 464 | 50 | 14 | HP:0011339 |
| HumanPheno | Abnormality of the philtrum | ATP6V1A PPP1R12A QRICH1 BRAF UBAP2L MED12L NOVA2 FLII FLNA DYRK1A APC RFX7 PIEZO2 IGF1R MED25 DOCK7 ANKRD17 MAN1B1 | 9.72e-05 | 726 | 50 | 18 | HP:0000288 |
| HumanPheno | Abnormal motivation | ATP6V1A RELN PPP1R12A ATP8B1 BCS1L TULP1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A SLC26A9 ADGRL1 CHD7 RFX7 GRM7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 9.78e-05 | 1263 | 50 | 25 | HP:5200275 |
| HumanPheno | Abnormal volitional state | ATP6V1A RELN PPP1R12A ATP8B1 BCS1L TULP1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A SLC26A9 ADGRL1 CHD7 RFX7 GRM7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 9.78e-05 | 1263 | 50 | 25 | HP:0025780 |
| HumanPheno | Reduced impulse control | ATP6V1A RELN PPP1R12A TULP1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII DYRK1A ADGRL1 CHD7 RFX7 GRM7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 1.15e-04 | 1032 | 50 | 22 | HP:5200045 |
| HumanPheno | Abnormal renal pelvis morphology | BRAF GLI3 FLNA B4GAT1 DYRK1A APC LAMA3 CHD7 RFX7 PIEZO2 MED25 | 1.16e-04 | 300 | 50 | 11 | HP:0010944 |
| HumanPheno | Heterotopias/abnormal migration | ATP6V1A RELN PPP1R12A TULP1 KNL1 FLNA RPGRIP1L B4GAT1 DYRK1A ADGRL1 GRM7 DCHS1 MAN1B1 TP73 | 1.30e-04 | 477 | 50 | 14 | HP:0007317 |
| HumanPheno | Abnormality of neuronal migration | ATP6V1A RELN PPP1R12A TULP1 KNL1 FLNA RPGRIP1L B4GAT1 DYRK1A ADGRL1 GRM7 DCHS1 MAN1B1 TP73 | 1.30e-04 | 477 | 50 | 14 | HP:0002269 |
| HumanPheno | Syndactyly | PPP1R12A PLXND1 GLI3 FLII FLNA DYRK1A APC LAMA3 RFX7 PIEZO2 MED25 DCHS1 MAN1B1 | 1.31e-04 | 417 | 50 | 13 | HP:0001159 |
| HumanPheno | Abnormality of globe location | ATP6V1A RELN PPP1R12A QRICH1 ITGA3 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L DYRK1A APC CHD7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 1.34e-04 | 1122 | 50 | 23 | HP:0100886 |
| HumanPheno | Hypertelorism | ATP6V1A RELN PPP1R12A QRICH1 ITGA3 BRAF UBAP2L GLI3 MED12L KNL1 FLII FLNA RPGRIP1L APC CHD7 PIEZO2 MED25 DCHS1 MAN1B1 | 1.70e-04 | 830 | 50 | 19 | HP:0000316 |
| HumanPheno | Gray matter heterotopia | 2.29e-04 | 129 | 50 | 7 | HP:0002282 | |
| HumanPheno | Eclabion | 2.29e-04 | 172 | 50 | 8 | HP:0012472 | |
| HumanPheno | Abnormality of globe location or size | ATP6V1A RELN PPP1R12A QRICH1 ITGA3 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L B4GAT1 DYRK1A APC CHD7 PIEZO2 IGF1R MED25 DCHS1 ANKRD17 MAN1B1 | 2.40e-04 | 1246 | 50 | 24 | HP:0000489 |
| HumanPheno | Abnormal lip morphology | ATP6V1A PPP1R12A QRICH1 PLXND1 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L DYRK1A APC CHD7 RFX7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 ANKRD17 MAN1B1 | 2.49e-04 | 1249 | 50 | 24 | HP:0000159 |
| HumanPheno | Abnormal corpus callosum morphology | ATP6V1A RELN PPP1R12A BRAF GLI3 MED12L NOVA2 KNL1 FLII FLNA RPGRIP1L B4GAT1 DYRK1A GRM7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 TP73 | 2.81e-04 | 937 | 50 | 20 | HP:0001273 |
| HumanPheno | Aggressive behavior | ATP6V1A RELN TULP1 UBAP2L MED12L KNL1 FLII DYRK1A CHD7 RFX7 GRM7 MED25 DCHS1 MAN1B1 | 3.00e-04 | 516 | 50 | 14 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | ATP6V1A RELN TULP1 UBAP2L MED12L KNL1 FLII DYRK1A CHD7 RFX7 GRM7 MED25 DCHS1 MAN1B1 | 3.00e-04 | 516 | 50 | 14 | HP:0006919 |
| HumanPheno | Thin upper lip vermilion | QRICH1 UBAP2L MED12L KNL1 DYRK1A APC RFX7 PIEZO2 IGF1R ANKRD17 MAN1B1 | 3.42e-04 | 339 | 50 | 11 | HP:0000219 |
| HumanPheno | Thin lips | QRICH1 UBAP2L MED12L KNL1 DYRK1A APC RFX7 PIEZO2 IGF1R ANKRD17 MAN1B1 | 3.42e-04 | 339 | 50 | 11 | HP:0000213 |
| HumanPheno | Abnormality of corneal size | ABCA4 PPP1R12A DHX38 TULP1 UBAP2L GLI3 FLII FLNA RPGRIP1L B4GAT1 DYRK1A PIEZO2 MED25 | 3.59e-04 | 461 | 50 | 13 | HP:0001120 |
| HumanPheno | Everted lower lip vermilion | 3.63e-04 | 139 | 50 | 7 | HP:0000232 | |
| HumanPheno | Hypermetropia | ATP6V1A PPP1R12A TULP1 UBAP2L MED12L DYRK1A ADGRL1 PIEZO2 MED25 MAN1B1 | 3.89e-04 | 288 | 50 | 10 | HP:0000540 |
| HumanPheno | Congenital onset | ATP6V1A ZNF141 QRICH1 PLXND1 ITGA3 BCS1L TULP1 TUBB1 MET BRAF GLI3 KNL1 FLNA RPGRIP1L B4GAT1 DYRK1A LAMA3 CHD7 UGT1A1 PIEZO2 IGF1R MED25 DCHS1 | 4.20e-04 | 1206 | 50 | 23 | HP:0003577 |
| HumanPheno | Abnormality of the chin | BRAF UBAP2L MED12L FLII FLNA DYRK1A APC CHD7 RFX7 PIEZO2 MED25 MAN1B1 | 4.45e-04 | 409 | 50 | 12 | HP:0000306 |
| HumanPheno | Abnormal lower lip morphology | 4.81e-04 | 242 | 50 | 9 | HP:0000178 | |
| HumanPheno | Hypoplasia of the corpus callosum | ATP6V1A RELN GLI3 MED12L NOVA2 FLNA DYRK1A GRM7 IGF1R MED25 DOCK7 DCHS1 TP73 | 5.11e-04 | 478 | 50 | 13 | HP:0002079 |
| HumanPheno | Ptosis | ATP6V1A PPP1R12A QRICH1 PLXND1 BCS1L BRAF COQ8A GLI3 MED12L NOVA2 FLNA RPGRIP1L APC CHD7 PIEZO2 MED25 DCHS1 | 5.28e-04 | 754 | 50 | 17 | HP:0000508 |
| HumanPheno | Cerebellar malformation | ATP6V1A PPP1R12A TULP1 GLI3 NOVA2 KNL1 FLNA RPGRIP1L B4GAT1 CHD7 RFX7 PIEZO2 DCHS1 | 6.12e-04 | 487 | 50 | 13 | HP:0002438 |
| HumanPheno | Abnormal eyelid morphology | ATP6V1A PPP1R12A QRICH1 PLXND1 ITGA3 BRAF UBAP2L GLI3 MED12L NOVA2 KNL1 FLII FLNA DYRK1A APC LAMA3 CHD7 RFX7 PIEZO2 IGF1R MED25 DOCK7 DCHS1 ANKRD17 MAN1B1 | 6.18e-04 | 1408 | 50 | 25 | HP:0000492 |
| HumanPheno | Agenesis of corpus callosum | RELN PPP1R12A GLI3 MED12L KNL1 RPGRIP1L B4GAT1 PIEZO2 MED25 DCHS1 TP73 | 6.44e-04 | 365 | 50 | 11 | HP:0001274 |
| HumanPheno | Short 4th metacarpal | 6.55e-04 | 18 | 50 | 3 | HP:0010044 | |
| HumanPheno | Periventricular nodular heterotopia | 6.55e-04 | 18 | 50 | 3 | HP:0032388 | |
| HumanPheno | Bulbous nose | 6.58e-04 | 201 | 50 | 8 | HP:0000414 | |
| HumanPheno | Gray matter heterotopias | 6.99e-04 | 42 | 50 | 4 | HP:0002281 | |
| HumanPheno | Periventricular heterotopia | 6.99e-04 | 42 | 50 | 4 | HP:0007165 | |
| HumanPheno | Aplasia/Hypoplasia of the 4th metacarpal | 7.72e-04 | 19 | 50 | 3 | HP:0010042 | |
| HumanPheno | Broad nasal tip | 8.16e-04 | 159 | 50 | 7 | HP:0000455 | |
| HumanPheno | Abnormal metatarsal morphology | 8.16e-04 | 159 | 50 | 7 | HP:0001832 | |
| HumanPheno | Abnormal lower limb bone morphology | RELN ZNF141 B4GALNT1 MET UBAP2L GLI3 FLNA RPGRIP1L B4GAT1 DYRK1A APC LAMP2 CHD7 GRM7 PIEZO2 IGF1R MED25 DCHS1 | 9.21e-04 | 866 | 50 | 18 | HP:0040069 |
| Domain | Cadherin_C | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 1.02e-31 | 42 | 184 | 21 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 1.02e-31 | 42 | 184 | 21 | PF16492 |
| Domain | Cadherin_2 | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 9.48e-27 | 65 | 184 | 21 | PF08266 |
| Domain | Cadherin_N | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 9.48e-27 | 65 | 184 | 21 | IPR013164 |
| Domain | Cadherin_CS | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 6.04e-26 | 109 | 184 | 24 | IPR020894 |
| Domain | CADHERIN_1 | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 1.54e-25 | 113 | 184 | 24 | PS00232 |
| Domain | Cadherin | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 1.54e-25 | 113 | 184 | 24 | PF00028 |
| Domain | CADHERIN_2 | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 1.93e-25 | 114 | 184 | 24 | PS50268 |
| Domain | - | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 1.93e-25 | 114 | 184 | 24 | 2.60.40.60 |
| Domain | CA | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 2.42e-25 | 115 | 184 | 24 | SM00112 |
| Domain | Cadherin-like | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 3.03e-25 | 116 | 184 | 24 | IPR015919 |
| Domain | Cadherin | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 PCDHGA8 CDH7 | 4.71e-25 | 118 | 184 | 24 | IPR002126 |
| Domain | Cadherin_tail | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHGB4 PCDHGC3 PCDHGA8 | 2.46e-19 | 37 | 184 | 14 | PF15974 |
| Domain | Cadherin_CBD | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHGB4 PCDHGC3 PCDHGA8 | 2.46e-19 | 37 | 184 | 14 | IPR031904 |
| Domain | Tap1/ABCB2 | 9.65e-05 | 2 | 184 | 2 | IPR013306 | |
| Domain | ABC_Tap-like | 9.65e-05 | 2 | 184 | 2 | IPR013305 | |
| Domain | Tap2/ABCB3 | 9.65e-05 | 2 | 184 | 2 | IPR005293 | |
| Domain | Sp1_fam | 1.07e-04 | 10 | 184 | 3 | IPR030450 | |
| Domain | IPT | 1.34e-04 | 27 | 184 | 4 | SM00429 | |
| Domain | TIG | 2.33e-04 | 31 | 184 | 4 | PF01833 | |
| Domain | IPT | 2.64e-04 | 32 | 184 | 4 | IPR002909 | |
| Domain | HSP70 | 4.79e-04 | 16 | 184 | 3 | PF00012 | |
| Domain | HSP70_2 | 5.78e-04 | 17 | 184 | 3 | PS00329 | |
| Domain | HSP70_1 | 5.78e-04 | 17 | 184 | 3 | PS00297 | |
| Domain | HSP70_3 | 5.78e-04 | 17 | 184 | 3 | PS01036 | |
| Domain | Hsp_70_fam | 6.88e-04 | 18 | 184 | 3 | IPR013126 | |
| Domain | U2AF_small | 9.47e-04 | 5 | 184 | 2 | IPR009145 | |
| Domain | GPCR_2_latrophilin | 9.47e-04 | 5 | 184 | 2 | IPR003924 | |
| Domain | Mtc | 9.47e-04 | 5 | 184 | 2 | PF03820 | |
| Domain | Mtc | 9.47e-04 | 5 | 184 | 2 | IPR004686 | |
| Pathway | KEGG_ENDOCYTOSIS | 1.19e-05 | 181 | 110 | 9 | M1519 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 PCDHGC3 PCDHGA8 | 1.55e-32 | 72 | 197 | 22 | 10380929 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 CELSR3 PCDHGB4 PCDHGC3 PCDHGA8 | 2.26e-31 | 80 | 197 | 22 | 10716726 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 3.26e-31 | 68 | 197 | 21 | 11230163 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 2.56e-30 | 74 | 197 | 21 | 10817752 |
| Pubmed | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 6.65e-30 | 77 | 197 | 21 | 10835267 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | RELN PCDHB5 PCDHB1 PCDHGC5 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 | 2.85e-23 | 57 | 197 | 16 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | RELN PCDHB5 PCDHB1 PCDHGC5 PCDHGB2 PCDHGA10 PCDHGA7 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 | 1.79e-19 | 58 | 197 | 14 | 30377227 |
| Pubmed | PCDHGC5 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGB4 PCDHGC3 | 5.71e-15 | 15 | 197 | 8 | 23515096 | |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | BSN PCDHGC5 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGB4 PCDHGC3 | 2.32e-13 | 34 | 197 | 9 | 22884324 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHGC5 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGB4 PCDHGC3 | 2.59e-12 | 28 | 197 | 8 | 15347688 |
| Pubmed | BSN PCDHGC5 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGB4 PCDHGC3 | 2.98e-12 | 44 | 197 | 9 | 19029045 | |
| Pubmed | 1.22e-11 | 20 | 197 | 7 | 11322959 | ||
| Pubmed | KNTC1 SMG1 ACACB PPP1R12A LYST RYR2 UMODL1 BSN DTHD1 HSPA1L HSPA6 FLNA PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 CTDSPL2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 UBR4 PCDHGB4 TENM1 CCAR1 PCDHGC3 PCDHGA8 | 7.91e-10 | 1442 | 197 | 30 | 35575683 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 ATP6V1A PPP1R12A ATP8B1 BICD1 ASAP2 PTPN13 COQ8A GPR158 UBAP2L DCLK2 LAMA3 ADGRL1 BTAF1 PCDHB16 SFXN1 THADA IGF1R ZNF718 LRRC1 SFXN3 CCAR1 ANKRD17 TTC17 OLFM2 QSER1 PARD3 MAN1B1 | 2.70e-08 | 1489 | 197 | 28 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 KLF12 SP3 ACACB NEDD4 LARP4B ASAP2 BSN CTDSPL2 UBR4 CHD7 MLLT10 VPS37B CCDC87 TP73 | 2.83e-08 | 430 | 197 | 15 | 35044719 |
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 3.45e-08 | 7 | 197 | 4 | 9182820 | |
| Pubmed | PPP1R12A ARMCX4 NEDD4 HDAC3 GPR158 UBAP2L BSN FLII SGIP1 UBR4 DYRK1A APC CHD7 SFXN3 DOCK7 DCHS1 CCAR1 ANKRD17 DIXDC1 QSER1 PARD3 DCLK1 | 3.46e-08 | 963 | 197 | 22 | 28671696 | |
| Pubmed | 1.23e-07 | 9 | 197 | 4 | 12154121 | ||
| Pubmed | ATP6V1A ACACB HMGCS1 DHRS1 RYR2 MET LARP4B GPR158 UBAP2L DCLK2 BSN FLII FLNA SGIP1 UBR4 APC ADGRL1 VPS37B SFXN1 SFXN3 DOCK7 TENM1 DCLK1 | 1.52e-07 | 1139 | 197 | 23 | 36417873 | |
| Pubmed | 1.79e-07 | 3 | 197 | 3 | 25793500 | ||
| Pubmed | 1.85e-07 | 107 | 197 | 8 | 30995489 | ||
| Pubmed | 2.16e-07 | 24 | 197 | 5 | 24698270 | ||
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 4.90e-07 | 28 | 197 | 5 | 33523829 | |
| Pubmed | SMG1 SP1 SP2 KLF12 ACACB SEC24A RC3H1 DDOST HDAC3 LARP4B UBAP2L GLI3 USP27X CNOT10 UBR4 CHD7 HNRNPUL1 MLLT10 RFX7 SFXN1 ZNF611 CCAR1 ANKRD17 ATF1 QSER1 | 6.13e-07 | 1429 | 197 | 25 | 35140242 | |
| Pubmed | 6.86e-07 | 13 | 197 | 4 | 12231349 | ||
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 15790310 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 7.13e-07 | 4 | 197 | 3 | 10469592 | |
| Pubmed | 7.13e-07 | 4 | 197 | 3 | 27889927 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.13e-06 | 94 | 197 | 7 | 21542922 | |
| Pubmed | The role of Foxg1 and dorsal midline signaling in the generation of Cajal-Retzius subtypes. | 1.30e-06 | 15 | 197 | 4 | 17928452 | |
| Pubmed | 1.78e-06 | 5 | 197 | 3 | 10547281 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.78e-06 | 5 | 197 | 3 | 12629516 | |
| Pubmed | 2.24e-06 | 17 | 197 | 4 | 18279309 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.51e-06 | 202 | 197 | 9 | 33005030 | |
| Pubmed | Differential intranuclear organization of transcription factors Sp1 and Sp3. | 3.54e-06 | 6 | 197 | 3 | 15987735 | |
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 5367369 | ||
| Pubmed | 3.54e-06 | 6 | 197 | 3 | 16201967 | ||
| Pubmed | Gli3 is required for the specification and differentiation of preplate neurons. | 3.62e-06 | 19 | 197 | 4 | 16168404 | |
| Pubmed | SMG1 DHX38 DDOST COQ8A PZP USP13 ARHGAP23 APC BTAF1 DOCK7 CCAR1 ANKRD17 QSER1 PCDHGC3 MAN1B1 | 5.11e-06 | 650 | 197 | 15 | 38777146 | |
| Pubmed | Differential expression of individual gamma-protocadherins during mouse brain development. | 6.16e-06 | 7 | 197 | 3 | 15964765 | |
| Pubmed | ATP6V1A ACACB SEC24A PLXND1 RYR2 MET PTPN13 GLI3 RPGRIP1L APC HNRNPUL1 PKHD1L1 SFXN1 THADA DOCK7 PARD3 | 1.02e-05 | 777 | 197 | 16 | 35844135 | |
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 1.15e-05 | 25 | 197 | 4 | 15820306 | |
| Pubmed | KLF12 PPP1R12A DHX38 LARP4B PTPN13 BRAF COQ8A UBAP2L FLNA POLD2 DYRK1A APC CHD7 SFXN3 ANKRD17 QSER1 PARD3 DCLK1 MAN1B1 | 1.46e-05 | 1084 | 197 | 19 | 11544199 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.67e-05 | 195 | 197 | 8 | 17110338 | |
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 2.09e-05 | 10 | 197 | 3 | 9027500 | |
| Pubmed | 2.09e-05 | 10 | 197 | 3 | 22969705 | ||
| Pubmed | Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. | 2.09e-05 | 10 | 197 | 3 | 15619633 | |
| Pubmed | 2.10e-05 | 146 | 197 | 7 | 29688375 | ||
| Pubmed | A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. | 2.86e-05 | 11 | 197 | 3 | 8247543 | |
| Pubmed | 3.17e-05 | 32 | 197 | 4 | 18850735 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 1946428 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 1473153 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 25193700 | ||
| Pubmed | Analysis of the modifying effects of TAP 1/2 genes on cystic fibrosis phenotype. | 3.19e-05 | 2 | 197 | 2 | 12026214 | |
| Pubmed | Transport protein genes in the murine MHC: possible implications for antigen processing. | 3.19e-05 | 2 | 197 | 2 | 2270487 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 25538045 | ||
| Pubmed | Structural arrangement of the transmission interface in the antigen ABC transport complex TAP. | 3.19e-05 | 2 | 197 | 2 | 19297616 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 18055444 | ||
| Pubmed | Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. | 3.19e-05 | 2 | 197 | 2 | 10368286 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 16216677 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 7538543 | ||
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 3.19e-05 | 2 | 197 | 2 | 31164147 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 21729677 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 28405734 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22450351 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 35485366 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 26807725 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 19378335 | ||
| Pubmed | The peptide-binding motif for the human transporter associated with antigen processing. | 3.19e-05 | 2 | 197 | 2 | 7500034 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 20528922 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 15951564 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 17189620 | ||
| Pubmed | Association of TAP1 and TAP2 genes with susceptibility to pulmonary tuberculosis in Koreans. | 3.19e-05 | 2 | 197 | 2 | 25846714 | |
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 3.19e-05 | 2 | 197 | 2 | 22464952 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12018331 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12234057 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 20146801 | ||
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 3.19e-05 | 2 | 197 | 2 | 8845379 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 9260681 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 14679198 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 15887980 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12777979 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12645939 | ||
| Pubmed | Allelic variation in the mouse Tap-1 and Tap-2 transporter genes. | 3.19e-05 | 2 | 197 | 2 | 9164943 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 12777379 | ||
| Pubmed | [Distribution of tap1 and tap2 loci allelic and genotypic frequencies in Chinese Hans]. | 3.19e-05 | 2 | 197 | 2 | 19549407 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 28148261 | ||
| Pubmed | Association of TAP gene polymorphisms and risk of cervical intraepithelial neoplasia. | 3.19e-05 | 2 | 197 | 2 | 24288424 | |
| Pubmed | TAP1 and TAP2 gene polymorphisms in childhood cystic echinococcosis. | 3.19e-05 | 2 | 197 | 2 | 20193774 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 1341900 | ||
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 3.19e-05 | 2 | 197 | 2 | 15816870 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 27325282 | ||
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 3.19e-05 | 2 | 197 | 2 | 14608051 | |
| Pubmed | Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. | 3.19e-05 | 2 | 197 | 2 | 8294864 | |
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 8955196 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 29879547 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 18723765 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 14766015 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 11381133 | ||
| Pubmed | 3.19e-05 | 2 | 197 | 2 | 22989262 | ||
| Interaction | PCDHGB2 interactions | PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHB3 PCDHGB4 PCDHGC3 | 7.01e-12 | 44 | 187 | 10 | int:PCDHGB2 |
| Interaction | PCDHGB1 interactions | PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA9 PCDHGA7 ADGRL1 PCDHB16 CELSR3 PCDHGB4 DCHS1 PCDHGC3 | 1.28e-10 | 77 | 187 | 11 | int:PCDHGB1 |
| Interaction | PCDHGA6 interactions | 1.60e-09 | 24 | 187 | 7 | int:PCDHGA6 | |
| Interaction | PCDHA9 interactions | 1.46e-08 | 32 | 187 | 7 | int:PCDHA9 | |
| Interaction | PCDHGA4 interactions | 2.30e-08 | 34 | 187 | 7 | int:PCDHGA4 | |
| Interaction | PCDHGB3 interactions | 4.88e-07 | 8 | 187 | 4 | int:PCDHGB3 | |
| Interaction | PCDHGA10 interactions | 6.82e-07 | 19 | 187 | 5 | int:PCDHGA10 | |
| Interaction | FHL2 interactions | SP1 SP2 KLF12 SP3 QRICH1 ITGA3 SAXO1 LARP4B KNL1 CNOT10 DYRK1A APC CCAR1 ANKRD17 ATF1 QSER1 | 9.48e-07 | 396 | 187 | 16 | int:FHL2 |
| Interaction | PCDHGA12 interactions | 1.44e-06 | 10 | 187 | 4 | int:PCDHGA12 | |
| Interaction | PCDHGA5 interactions | 1.89e-06 | 63 | 187 | 7 | int:PCDHGA5 | |
| Interaction | PCDHGB5 interactions | 2.70e-06 | 43 | 187 | 6 | int:PCDHGB5 | |
| Interaction | H2BC5 interactions | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHGB4 PCDHGC3 PCDHGA8 | 2.74e-06 | 331 | 187 | 14 | int:H2BC5 |
| Interaction | PCDHGA7 interactions | 2.98e-06 | 25 | 187 | 5 | int:PCDHGA7 | |
| Interaction | PCDHB7 interactions | 3.10e-06 | 44 | 187 | 6 | int:PCDHB7 | |
| Interaction | PCDHGA8 interactions | 7.76e-06 | 5 | 187 | 3 | int:PCDHGA8 | |
| Interaction | SMPD2 interactions | 1.92e-05 | 89 | 187 | 7 | int:SMPD2 | |
| Interaction | LTBP1 interactions | 2.38e-05 | 92 | 187 | 7 | int:LTBP1 | |
| Interaction | PCDHGB6 interactions | 2.68e-05 | 7 | 187 | 3 | int:PCDHGB6 | |
| Interaction | DCHS1 interactions | 3.10e-05 | 20 | 187 | 4 | int:DCHS1 | |
| Interaction | PCDHB3 interactions | PCDHB5 PCDHGB2 PCDHGA10 PCDHGA5 PCDHB7 PCDHB3 PCDHB16 MAN1B1 | 5.24e-05 | 141 | 187 | 8 | int:PCDHB3 |
| Interaction | RETSAT interactions | 5.95e-05 | 106 | 187 | 7 | int:RETSAT | |
| Interaction | RCOR1 interactions | SP1 KLF12 ACACB PPP1R12A HDAC3 PTPN13 HSPA6 KNL1 FLII FLNA UBR4 APC CHD7 DOCK7 ANKRD17 | 6.09e-05 | 494 | 187 | 15 | int:RCOR1 |
| Interaction | PCDHB2 interactions | 1.23e-04 | 11 | 187 | 3 | int:PCDHB2 | |
| Interaction | LRRC31 interactions | 1.30e-04 | 205 | 187 | 9 | int:LRRC31 | |
| Interaction | FMR1 interactions | SMG1 RC3H1 NEDD4 HDAC3 LARP4B FBXO4 UBAP2L BSN UBR4 APC CHD7 DOCK7 ANKRD17 DIXDC1 PARD3 | 1.50e-04 | 536 | 187 | 15 | int:FMR1 |
| Interaction | RYK interactions | RYK MET ADGRA3 PCDHGA11 PCDHGA7 PCDHGA5 CELSR3 DCHS1 PCDHGC3 | 1.68e-04 | 212 | 187 | 9 | int:RYK |
| Interaction | USP54 interactions | 1.68e-04 | 212 | 187 | 9 | int:USP54 | |
| Interaction | C1orf54 interactions | 1.71e-04 | 167 | 187 | 8 | int:C1orf54 | |
| Cytoband | 5q31 | PCDHB5 HDAC3 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 3.93e-30 | 115 | 197 | 22 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | SEC24A PCDHB5 HDAC3 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 4.48e-22 | 298 | 197 | 23 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHB5 PCDHB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHB14 PCDHB12 PCDHB7 PCDHB3 PCDHB16 PCDHGB4 PCDHGC3 PCDHGA8 | 2.59e-29 | 64 | 139 | 21 | 20 |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 3.61e-05 | 9 | 139 | 3 | 755 | |
| GeneFamily | Heat shock 70kDa proteins | 2.79e-04 | 17 | 139 | 3 | 583 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.05e-04 | 181 | 139 | 7 | 694 | |
| GeneFamily | Sideroflexins | 5.78e-04 | 5 | 139 | 2 | 746 | |
| GeneFamily | PDZ domain containing | 1.15e-03 | 152 | 139 | 6 | 1220 | |
| GeneFamily | Doublecortin superfamily | 2.54e-03 | 10 | 139 | 2 | 1369 | |
| GeneFamily | ATP binding cassette subfamily B | 3.08e-03 | 11 | 139 | 2 | 806 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 3.08e-03 | 11 | 139 | 2 | 559 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.57e-03 | 40 | 139 | 3 | 321 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.38e-03 | 43 | 139 | 3 | 409 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | LYST PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 TPTE2 LAMA3 PCDHGB4 PCDHGC3 PCDHGA8 | 9.13e-10 | 222 | 189 | 14 | M16955 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 SEC24A PPP1R12A ATP8B1 RYK BICD1 NEDD4 LARP4B ASAP2 PTPN13 ADGRA3 USP13 DYRK1A APC BTAF1 TFPI IGF1R ANKRD17 BICRAL PARD3 | 4.17e-06 | 856 | 189 | 20 | M4500 |
| CoexpressionAtlas | PP_RBC_top-relative-expression-ranked_2500_k-means-cluster#3 | COQ8A HSPA6 HSPA7 PCDHGC5 PCDHGB6 PCDHGB2 PCDHB14 PCDHB12 PCDHB3 | 1.05e-05 | 158 | 185 | 9 | PP_RBC_2500_K3 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | RELN SNPH ABCA4 GINM1 ATP8B1 PLXND1 EPB41L4A SPTBN5 KIAA1549L PZP NOVA2 FLNA SGIP1 ARHGAP23 PCDHGA11 LAMP2 PKHD1L1 TFPI PIEZO2 MANSC1 SFXN3 DCHS1 | 2.33e-05 | 936 | 185 | 22 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | PPP1R12A RC3H1 NEDD4 ASAP2 UBAP2L USP27X ADGRA3 KNL1 CTDSPL2 DYRK1A APC CHD7 HNRNPUL1 THADA ANKRD17 QSER1 | 3.66e-05 | 564 | 185 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | PPP1R12A USP27X TENT2 CTDSPL2 DYRK1A CHD7 HNRNPUL1 THADA DIXDC1 | 3.67e-05 | 185 | 185 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SP3 DHX38 BRAF GLI3 USP27X TENT2 USP13 APC CHD7 RFX7 PREX2 SFXN1 CCAR1 PARD3 | 6.64e-05 | 469 | 185 | 14 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | KNTC1 BICD1 NEDD4 MED12L ADGRA3 KNL1 ARHGAP23 IFI44 TFPI IGF1R MANSC1 DOCK7 QSER1 | 8.87e-05 | 422 | 185 | 13 | GSM399442_500 |
| CoexpressionAtlas | cerebral cortex | CELF4 SNPH B4GALNT1 KIAA1549L GPR158 GPR75 MED12L DCLK2 BSN NOVA1 NOVA2 SGIP1 PCDHGC5 B4GAT1 PCDHGB6 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA1 APC ADGRL1 GRM7 CELSR3 OLFM2 PCDHGC3 CDH7 DCLK1 | 1.16e-04 | 1428 | 185 | 27 | cerebral cortex |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CPNE8 ITGA3 CAPN13 MET PTPN13 GLI3 ARHGAP23 LAMA3 PDLIM1 CDH7 TP73 | 1.05e-09 | 199 | 190 | 11 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DDOST PCDHGC5 PCDHGB3 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA1 PCDHB7 PCDHGB4 PCDHGC3 | 7.20e-09 | 184 | 190 | 10 | 629cfed10e1112cf30f6a828ce9efbbc6b207789 |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.33e-08 | 177 | 190 | 9 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DDOST PCDHGC5 PCDHGB3 PCDHGB2 PCDHGA10 PCDHGA9 POLD2 PCDHB7 PCDHGC3 | 1.12e-07 | 186 | 190 | 9 | 10edc3dd96181b6f7bd07a5ad0862ba9fa6a9cb9 |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | ATP8B1 EPB41L4A MET KIAA1549L NOVA2 PKHD1L1 PREX2 PDLIM1 LRRC1 | 1.17e-07 | 187 | 190 | 9 | 2d20193a6cacdfa4877457c97b0077408942186c |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-07 | 192 | 190 | 9 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-07 | 196 | 190 | 9 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-07 | 196 | 190 | 9 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.18e-07 | 163 | 190 | 8 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.95e-07 | 166 | 190 | 8 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.13e-07 | 173 | 190 | 8 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-07 | 177 | 190 | 8 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-07 | 177 | 190 | 8 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-07 | 177 | 190 | 8 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.35e-06 | 185 | 190 | 8 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-06 | 185 | 190 | 8 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.35e-06 | 185 | 190 | 8 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 186 | 190 | 8 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 186 | 190 | 8 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 189 | 190 | 8 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-06 | 190 | 190 | 8 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.64e-06 | 190 | 190 | 8 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 1.78e-06 | 192 | 190 | 8 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.78e-06 | 192 | 190 | 8 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.78e-06 | 192 | 190 | 8 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.85e-06 | 193 | 190 | 8 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 193 | 190 | 8 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 194 | 190 | 8 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.92e-06 | 194 | 190 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 194 | 190 | 8 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.07e-06 | 196 | 190 | 8 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.15e-06 | 197 | 190 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.15e-06 | 197 | 190 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 198 | 190 | 8 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-06 | 198 | 190 | 8 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 199 | 190 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 199 | 190 | 8 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.40e-06 | 140 | 190 | 7 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 200 | 190 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-06 | 157 | 190 | 7 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-06 | 157 | 190 | 7 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 6.04e-06 | 161 | 190 | 7 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-06 | 166 | 190 | 7 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.38e-06 | 166 | 190 | 7 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.68e-06 | 167 | 190 | 7 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-06 | 168 | 190 | 7 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.98e-06 | 168 | 190 | 7 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.31e-06 | 172 | 190 | 7 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.00e-05 | 174 | 190 | 7 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-05 | 176 | 190 | 7 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-05 | 176 | 190 | 7 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 176 | 190 | 7 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.34e-05 | 182 | 190 | 7 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 182 | 190 | 7 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 1.34e-05 | 182 | 190 | 7 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.34e-05 | 182 | 190 | 7 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.39e-05 | 183 | 190 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 183 | 190 | 7 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 184 | 190 | 7 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.55e-05 | 186 | 190 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-05 | 186 | 190 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | (4)_Lymph_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.55e-05 | 186 | 190 | 7 | 6b3afc2ae870ff73e30a60ce84fcee0eb365d809 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.60e-05 | 187 | 190 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 188 | 190 | 7 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 188 | 190 | 7 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.66e-05 | 188 | 190 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 126 | 190 | 6 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 126 | 190 | 6 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 126 | 190 | 6 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 126 | 190 | 6 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.70e-05 | 126 | 190 | 6 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 189 | 190 | 7 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 189 | 190 | 7 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.77e-05 | 190 | 190 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 190 | 190 | 7 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.77e-05 | 190 | 190 | 7 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 190 | 190 | 7 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.77e-05 | 190 | 190 | 7 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 190 | 190 | 7 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.77e-05 | 190 | 190 | 7 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 191 | 190 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 191 | 190 | 7 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-05 | 191 | 190 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.90e-05 | 192 | 190 | 7 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster | 1.90e-05 | 192 | 190 | 7 | cf989f26c0ebdc0cd12e1e41958f063e4fa3e468 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.90e-05 | 192 | 190 | 7 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 192 | 190 | 7 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 192 | 190 | 7 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 1.96e-05 | 193 | 190 | 7 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.96e-05 | 193 | 190 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 1.96e-05 | 193 | 190 | 7 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.96e-05 | 193 | 190 | 7 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 193 | 190 | 7 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 193 | 190 | 7 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 2.03e-05 | 194 | 190 | 7 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.10e-05 | 195 | 190 | 7 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.10e-05 | 195 | 190 | 7 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 195 | 190 | 7 | 717e6a66bad50e711442d71360b540789646b334 | |
| Drug | CID9959010 | 8.35e-07 | 39 | 191 | 6 | CID009959010 | |
| Drug | montmorillonite | 9.75e-07 | 40 | 191 | 6 | CID000517273 | |
| Drug | AC1L7AJI | CEACAM5 PTPN13 PCDHGC5 PCDHGB7 PCDHGA11 PCDHGA10 UGT1A6 DYRK1A APC UGT1A1 PCDHGC3 PCDHGA8 | 1.84e-06 | 256 | 191 | 12 | CID000003750 |
| Drug | lactofen | 5.39e-06 | 81 | 191 | 7 | CID000062276 | |
| Drug | AC1L1UVI | 6.64e-06 | 55 | 191 | 6 | CID000061263 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHGB4 PCDHGC3 PCDHGA8 | 1.23e-17 | 71 | 182 | 14 | EFO_0007878, EFO_0007979 |
| Disease | mental development measurement | PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 PCDHGB4 PCDHGA8 | 1.87e-16 | 25 | 182 | 10 | EFO_0008230 |
| Disease | Sarcosine measurement | 6.82e-11 | 23 | 182 | 7 | EFO_0021668 | |
| Disease | lymphocyte count | KLF12 SIGLEC5 PLXND1 LYST UMODL1 MED12L HSPA6 KNL1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 IFI44 CHD7 RFX7 PREX2 THADA NUDT3 PCDHGB4 PAPPA PCDHGC3 PCDHGA8 | 2.72e-08 | 1464 | 182 | 29 | EFO_0004587 |
| Disease | mean platelet volume | KLF12 PLXND1 LRCH1 TUBB1 PCDHGC5 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA10 PCDHGA9 PCDHGA7 PCDHGA5 PCDHGA1 DYRK1A CHD7 PDLIM1 DOCK7 PCDHGB4 PCDHGC3 PCDHGA8 | 3.74e-07 | 1020 | 182 | 22 | EFO_0004584 |
| Disease | cortical thickness | SP1 RELN B4GALNT1 ABCA4 PLXND1 LRCH1 UMODL1 GLI3 FLII FBXW10 CHD7 MLLT10 PCDHB16 THADA IGF1R DOCK7 PCDHGB4 CCAR1 QSER1 CFAP57 PARD3 | 5.70e-06 | 1113 | 182 | 21 | EFO_0004840 |
| Disease | dyslexia (implicated_via_orthology) | 3.78e-05 | 2 | 182 | 2 | DOID:4428 (implicated_via_orthology) | |
| Disease | adenoma (is_implicated_in) | 3.78e-05 | 2 | 182 | 2 | DOID:657 (is_implicated_in) | |
| Disease | emphysema | 6.31e-05 | 35 | 182 | 4 | EFO_0000464 | |
| Disease | MHC class I deficiency (is_implicated_in) | 1.13e-04 | 3 | 182 | 2 | DOID:0060009 (is_implicated_in) | |
| Disease | gastrinoma (is_marker_for) | 1.13e-04 | 3 | 182 | 2 | DOID:5577 (is_marker_for) | |
| Disease | Colorectal Carcinoma | ABCA4 BRAF GLI3 PZP APC PREX2 SFXN1 DUSP21 TENM1 DCHS1 CCAR1 OLFM2 CDH7 DCLK1 | 1.25e-04 | 702 | 182 | 14 | C0009402 |
| Disease | Benign neoplasm of stomach | 1.47e-04 | 17 | 182 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.47e-04 | 17 | 182 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.47e-04 | 17 | 182 | 3 | C0154060 | |
| Disease | Bare Lymphocyte Syndrome, Type I | 2.25e-04 | 4 | 182 | 2 | C1858266 | |
| Disease | MHC class I deficiency | 2.25e-04 | 4 | 182 | 2 | cv:C1858266 | |
| Disease | Stomach Carcinoma | 2.83e-04 | 21 | 182 | 3 | C0699791 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.26e-04 | 22 | 182 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | prostate carcinoma (is_marker_for) | 3.73e-04 | 23 | 182 | 3 | DOID:10286 (is_marker_for) | |
| Disease | reactive arthritis (is_implicated_in) | 3.74e-04 | 5 | 182 | 2 | DOID:6196 (is_implicated_in) | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 5.58e-04 | 6 | 182 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Junctional Epidermolysis Bullosa | 5.58e-04 | 6 | 182 | 2 | C0079301 | |
| Disease | Postaxial polydactyly type A | 5.58e-04 | 6 | 182 | 2 | C3887487 | |
| Disease | xanthurenate measurement | 7.49e-04 | 29 | 182 | 3 | EFO_0010551 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 7.79e-04 | 7 | 182 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 7.79e-04 | 7 | 182 | 2 | EFO_0020797 | |
| Disease | vascular dementia (is_implicated_in) | 7.79e-04 | 7 | 182 | 2 | DOID:8725 (is_implicated_in) | |
| Disease | cervical cancer (is_implicated_in) | 8.29e-04 | 30 | 182 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | brain connectivity measurement | 8.92e-04 | 400 | 182 | 9 | EFO_0005210 | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.32e-03 | 9 | 182 | 2 | 114550 | |
| Disease | X-11442 measurement | 1.32e-03 | 9 | 182 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.32e-03 | 9 | 182 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.32e-03 | 9 | 182 | 2 | EFO_0004739 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.32e-03 | 9 | 182 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Gastrointestinal Hemorrhage | 1.32e-03 | 9 | 182 | 2 | C0017181 | |
| Disease | Hepatocellular carcinoma | 1.32e-03 | 9 | 182 | 2 | cv:C2239176 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.32e-03 | 9 | 182 | 2 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 1.65e-03 | 10 | 182 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.65e-03 | 10 | 182 | 2 | EFO_0802185 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 1.79e-03 | 39 | 182 | 3 | EFO_0008298 | |
| Disease | diffuse scleroderma (is_implicated_in) | 2.01e-03 | 11 | 182 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | prostatic hypertrophy (is_marker_for) | 2.01e-03 | 11 | 182 | 2 | DOID:11132 (is_marker_for) | |
| Disease | histidine betaine (hercynine) measurement | 2.01e-03 | 11 | 182 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.01e-03 | 11 | 182 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.01e-03 | 11 | 182 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.01e-03 | 11 | 182 | 2 | EFO_0010219 | |
| Disease | neutrophil count, eosinophil count | 2.14e-03 | 213 | 182 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | obesity (implicated_via_orthology) | 2.24e-03 | 215 | 182 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | stromal cell-derived factor 1 alpha measurement | 2.38e-03 | 43 | 182 | 3 | EFO_0008293 | |
| Disease | endometrial carcinoma (is_implicated_in) | 2.40e-03 | 12 | 182 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | biliverdin measurement | 2.40e-03 | 12 | 182 | 2 | EFO_0021033 | |
| Disease | immunoglobulin isotype switching measurement | 2.54e-03 | 44 | 182 | 3 | EFO_0010128 | |
| Disease | very long-chain saturated fatty acid measurement | 2.54e-03 | 44 | 182 | 3 | EFO_0006796 | |
| Disease | glucose measurement | 2.58e-03 | 380 | 182 | 8 | EFO_0004468 | |
| Disease | neuroimaging measurement | SP1 RELN CELF4 PLXND1 LRCH1 BICD1 GLI3 APC CHD7 MLLT10 THADA PAPPA QSER1 PARD3 DCLK1 | 2.68e-03 | 1069 | 182 | 15 | EFO_0004346 |
| Disease | Adenocarcinoma of large intestine | 2.99e-03 | 96 | 182 | 4 | C1319315 | |
| Disease | nephroblastoma (is_implicated_in) | 3.28e-03 | 14 | 182 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | 3-hydroxyphenylacetic acid measurement | 3.28e-03 | 14 | 182 | 2 | EFO_0010448 | |
| Disease | Schizophrenia | SP1 KLF12 RELN MET HDAC3 HSPA1L TAP1 TAP2 APC GRM7 ERVK-8 DIXDC1 DCLK1 | 3.42e-03 | 883 | 182 | 13 | C0036341 |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 3.77e-03 | 15 | 182 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | JT interval | 4.52e-03 | 248 | 182 | 6 | EFO_0007885 | |
| Disease | gallstones | 4.56e-03 | 108 | 182 | 4 | EFO_0004210 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.84e-03 | 17 | 182 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 4.84e-03 | 17 | 182 | 2 | EFO_0021969 | |
| Disease | endometriosis | 4.88e-03 | 252 | 182 | 6 | EFO_0001065 | |
| Disease | granulocyte count | 5.07e-03 | 254 | 182 | 6 | EFO_0007987 | |
| Disease | response to tenofovir, creatinine clearance measurement | 5.18e-03 | 112 | 182 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | serum IgG glycosylation measurement | 5.37e-03 | 523 | 182 | 9 | EFO_0005193 | |
| Disease | Adrenocortical carcinoma | 5.42e-03 | 18 | 182 | 2 | C0206686 | |
| Disease | urate measurement, spine bone mineral density | 5.55e-03 | 58 | 182 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | smoking status measurement | CPNE8 CELF4 RYR2 EBF2 MET UBAP2L MED12L COL16A1 CHD7 MLLT10 GRM7 IGF1R BICRAL DIXDC1 QSER1 | 5.68e-03 | 1160 | 182 | 15 | EFO_0006527 |
| Disease | Pancreatic carcinoma | 6.04e-03 | 19 | 182 | 2 | C0235974 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 6.04e-03 | 19 | 182 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | Cannabis use, age at onset | 6.04e-03 | 19 | 182 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 6.10e-03 | 60 | 182 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 6.10e-03 | 60 | 182 | 3 | C4722327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNTYTNVIENGNSNK | 1181 | Q5DID0 | |
| QTSRPQNTQYRNGFL | 176 | P60509 | |
| TGQLPYSNINNRDQI | 651 | P15056 | |
| NTRNYEGQTPLAVSI | 241 | Q9H672 | |
| QSRPRTSGASYLQNL | 866 | Q96G01 | |
| NGAAYSNQAVQVRPS | 196 | Q05D32 | |
| PGIVSNYNNSILARV | 91 | P78363 | |
| LGTNVSYPNNLLRNL | 201 | O43505 | |
| SLPQGAQYNISALVT | 266 | Q00973 | |
| SVSEQNAYRAGLQPV | 71 | Q13686 | |
| AGLTTQTPANYQLTQ | 51 | Q8IX12 | |
| NGYPQISLEVNSQER | 126 | Q07092 | |
| NNGRLVVSQLNPYTL | 286 | O94910 | |
| ITAAANIKNYGSRPN | 891 | Q8IWK6 | |
| RATNQISPAQVQGYF | 386 | Q9Y276 | |
| NRQIIGYVIGTQQAT | 76 | P06731 | |
| LVQQYEGQQRSPSES | 201 | Q155Q3 | |
| QNQITFLQGSYTRGI | 326 | Q5XX13 | |
| DDQQGSRYSVIPQIQ | 266 | Q9UKT5 | |
| NQGYIRNTSSISPRG | 446 | Q9HAK2 | |
| NYSETPLQLAAAVGN | 686 | A6QL63 | |
| VSLQQLTYGNVSPIQ | 51 | Q6PIY7 | |
| LAALGSLTQNPQYRQ | 96 | Q6MZZ7 | |
| YPVLSILTQNGADVN | 181 | A6NGH8 | |
| NLTVYSNPRQETGIA | 701 | Q13627 | |
| NSQDVQGYITNQSPE | 791 | O75179 | |
| VGLYSQRANTLQSNT | 546 | Q9NVE4 | |
| QQGAVRPQTLNFSSR | 281 | Q9P2D1 | |
| TVTYPLNSNVQLAGL | 2131 | Q5H9R4 | |
| QFTGTASNALRQPYI | 1131 | O43520 | |
| GSLASVLAQYSPQQL | 351 | Q01581 | |
| LQERVVNSQYGTQPQ | 646 | Q5TC82 | |
| LGTYNVIPLNNEQSS | 716 | P20742 | |
| YTTNQNAGNIVVSRL | 336 | O95897 | |
| DVGTNSLQSYQLSPN | 161 | Q9Y5G6 | |
| DIGSNTVQNYTISPN | 161 | Q9Y5E4 | |
| ATVLAIPQGQQQSYV | 266 | Q2TAL8 | |
| SGQAQIYSTAQLPSL | 321 | Q2KHR3 | |
| QLPSLLSVSQSQNYG | 331 | Q2KHR3 | |
| RQNVYIPGSNATLTN | 891 | Q9Y5G8 | |
| DVGVNSLQSYQLSPN | 161 | Q9Y5G5 | |
| QNVYIPGSNATLTNA | 896 | Q9Y5H2 | |
| IYGPGNLSTNNNTLR | 391 | Q8TD20 | |
| QNVYIPGSNATLTNA | 891 | Q9Y5F9 | |
| DIGSNTLQNYQLSPS | 161 | Q9UN71 | |
| NVYIPGSNATLTNAA | 891 | Q9Y5F8 | |
| VYRAQVSENSPNGSL | 246 | Q9Y5F3 | |
| GQSTDNSLLGYPQQI | 266 | Q9BYG5 | |
| TRDQNQQCSYIPGSV | 96 | Q16558 | |
| GQRNYLPNFIQSVLS | 36 | Q15124 | |
| REVYTSNNQLGGVQI | 1971 | O00763 | |
| QNQITFLQGSYTRGI | 326 | O95170 | |
| TQYNLTVAAADRGQP | 2566 | Q96JQ0 | |
| PGLLRAAQAALQYQS | 41 | A6NCF5 | |
| AQQPSLYQIRTNGSA | 1051 | Q13045 | |
| QQSPISNYSNSGLEL | 716 | P10071 | |
| QQAGSVVLSPSYNSR | 1956 | Q86YW9 | |
| PLSSGTQYNRVNLTL | 131 | Q16787 | |
| ATDNYTLQINPNSGL | 1031 | P46934 | |
| RQTPYNNVQSRINTG | 146 | Q68CZ1 | |
| VRGSYNSSNNFQQPL | 1151 | Q5T848 | |
| QVYVNDLPVNSGVTR | 71 | Q9NU53 | |
| TLKQTSFQRGEPQNY | 186 | Q96MR6 | |
| QIRQSTAYSLHQPQG | 286 | O43150 | |
| QAGQTRTRIQNPSAY | 456 | Q92615 | |
| GQASPQLYAASLLQR | 2911 | Q9UPA5 | |
| SDNVNLPQGVRTIYT | 96 | O15075 | |
| SDNVNLPQGVRTIYT | 111 | Q8N568 | |
| LNPGNYTARIQATSL | 896 | P08069 | |
| QLVTNPYQATIDGVR | 326 | P49005 | |
| YVLPSQTLNSQGSSQ | 1371 | Q9Y4D7 | |
| QSAGNPNYRRNITLA | 501 | P26006 | |
| ETLRQGYSANNGTPV | 141 | O95989 | |
| DVGVNSLQSYQLSPN | 161 | Q9Y5G4 | |
| RQNVYIPGSNATLTN | 896 | Q9Y5H3 | |
| RQNVYIPGSNATLTN | 891 | Q9Y5G2 | |
| NARLTYSIVGNQVQG | 486 | Q9Y5F6 | |
| NVYIPGSNATLTNAA | 906 | Q9Y5F6 | |
| IVISSQYPGQANRTA | 86 | P09131 | |
| IRNEGSQPAYRTNQQ | 506 | Q8NG66 | |
| PYNSQGQAIVERTNR | 736 | P63132 | |
| LQSNGSQYSPNEIRE | 516 | Q9Y2L9 | |
| SNLTLNTGNVYNPTA | 326 | Q9H8J5 | |
| RVQPFNVTQGKYSTA | 351 | P13473 | |
| SNLGSQVPLAAYNLA | 606 | Q8NG31 | |
| SINQRIQNSSGTDYP | 1781 | P50748 | |
| IANDQGNRTTPSYVA | 31 | P34931 | |
| NVNGQTISLYRFLPN | 181 | Q8N9Z9 | |
| QYQVPGNLSAAQVAA | 271 | Q71SY5 | |
| QLDQSALNYSGNTVP | 1696 | Q6ZVL6 | |
| NVYIPGSNATLTNAA | 891 | Q9Y5G1 | |
| NVYIPGSNATLTNAA | 896 | Q9UN70 | |
| QVTTINAHRSYLPGQ | 181 | Q13219 | |
| NISYANVAGPVANSN | 211 | Q9UNW9 | |
| GSPAATQAAQYLISQ | 461 | Q9UNW9 | |
| SAVQKAAPGSQRYSQ | 271 | P39656 | |
| PYNSQGQAIVERTNR | 736 | P63135 | |
| PYNSQGQAIVERTNR | 736 | Q9BXR3 | |
| QHVQTRGYTKSPNQL | 281 | O95800 | |
| RYTGASLQGATQLNN | 106 | O15379 | |
| LANDQGNRTTPSYVA | 31 | P48741 | |
| QSLPENIGNLYNLAS | 141 | Q9BTT6 | |
| TRVPSGGYSSINNVQ | 631 | Q9UKM7 | |
| GTNAQVNYSLLPSQD | 481 | Q9Y5F1 | |
| TPNNRNQGVLLEYSV | 2586 | P78509 | |
| IASSQLSPRLQYFGQ | 571 | Q13349 | |
| AAPGQTQANSLTVYL | 676 | Q9NRJ7 | |
| NLSQYVDDPVTGRQS | 221 | O15350 | |
| PYNSQGQAIVERTNR | 736 | Q9QC07 | |
| DVGSNSLQNYTISPN | 161 | Q9Y5E9 | |
| GTNAQVIYSLLPSQD | 481 | Q9Y5E2 | |
| TKYNSPTNFQIDGRN | 106 | Q8TCB0 | |
| QASNVSNYSGQTLQP | 151 | Q6AI39 | |
| IYPQSLNFANRQGSA | 566 | Q96N67 | |
| NYRIILSGTPIQNNV | 1426 | O14981 | |
| TKNQNRGNPAVSYVR | 4121 | Q9Y6R7 | |
| RVANPSGNLTETYVQ | 1296 | P21333 | |
| EGNIVIGYSISQQRQ | 71 | Q9H6D8 | |
| LRNSSPCGLNVQQIY | 186 | Q6PIV2 | |
| YPGVAQSINSDVNNL | 361 | Q8NI60 | |
| INLQSSYLNPNSLEG | 261 | Q6ZMT9 | |
| TNNLPNLLEYGNITA | 3116 | Q99698 | |
| SLYQNTINPSTLGQF | 161 | Q5VTH9 | |
| DPRVFQLQQSGQLYT | 606 | Q7Z6J4 | |
| VYTAVRSPGNVNNTI | 196 | Q9Y4X4 | |
| QYQTTNTSNPGYRLI | 481 | Q14831 | |
| LANDQGNRTTPSYVA | 31 | P17066 | |
| GNSARVVYSILQGQP | 186 | Q9ULB5 | |
| NSAISYQITGGNTRN | 786 | Q9NYQ7 | |
| NNAYAGVQTILNTRN | 91 | Q96LJ7 | |
| PVNTAAQLGAYAIQS | 131 | Q9HCS5 | |
| QGLSQPSTQTTQYLR | 271 | P34925 | |
| NYLRTQTGNNTTVNI | 3856 | Q92736 | |
| SRGQSQFNVYEVVNP | 256 | Q86YQ8 | |
| SQGVQQPSIYSFSQI | 11 | Q9H596 | |
| LGIPSQQVASQSSYL | 196 | A0A1W2PPM1 | |
| ETLSQGQSQRPSRQY | 451 | Q12923 | |
| DVGRNSLQNYTITPN | 161 | Q9Y5E6 | |
| SELGTNNVSAFQPYQ | 106 | Q8TEW0 | |
| TARVITNQYNNPAGL | 136 | O00151 | |
| RNPPGASTYNKNSNI | 721 | Q9BUJ2 | |
| LNISYANVTGPVANS | 251 | P51513 | |
| GTPAATQAAQYLITQ | 476 | P51513 | |
| RQNVYIPGSNATLTN | 891 | Q9Y5H4 | |
| SQNGSCRQVQYPLTD | 1016 | P08581 | |
| FITYNLNSQSPGVRQ | 666 | Q6YHU6 | |
| SRNIVQNYRAGVVTP | 46 | Q9BWM7 | |
| NYSNRSGDTPITVRQ | 131 | Q9BWM7 | |
| VNYTNRSGDAPLTVN | 131 | Q9H9B4 | |
| RIYKPVSQAGSQQSS | 441 | Q8IYX7 | |
| NNNQTPANGTSVSYI | 611 | Q7LBE3 | |
| SSQESVSQGYNFQLP | 41 | O95486 | |
| SAYRSSVLSNQQPGL | 876 | O95486 | |
| YGLQPSNSAVVSRQR | 56 | Q96Q15 | |
| SYGLQPSNSAVVSRQ | 51 | Q6P435 | |
| NVSYAPQTITIFRNG | 231 | O15389 | |
| APLTAQGSQQYRALS | 271 | Q9H4B7 | |
| TVAALLQNLYQPTGG | 546 | Q03518 | |
| TVAALLQNLYQPTGG | 511 | Q03519 | |
| QENTQSTYRVNPDGS | 1711 | Q9UKZ4 | |
| PVNAVTLTYNGNKNS | 1781 | P14410 | |
| SQRRQGQPIYNISSL | 446 | O15079 | |
| QYVTNVPVALNGNIT | 251 | P08047 | |
| SAEQLRQRYPGNSTQ | 956 | Q9NRC6 | |
| VSSLQIRYDQPGNSS | 691 | P55197 | |
| YSDEQLNSGRQSPSQ | 1031 | P25054 | |
| YAQTSDGQQILVPSN | 151 | P18846 | |
| TAADPLQQAYAGVQQ | 371 | Q9BZC1 | |
| NNNPLYSRQGEVLAS | 161 | Q6IBW4 | |
| QNTVYNDGQSSAIPV | 441 | Q9H9A5 | |
| QNPQRGYSTNVASLR | 386 | O00294 | |
| NYRNLVSLGVSISNP | 36 | Q3SXZ3 | |
| LQLPTNSGNNENKYS | 351 | A6NNY8 | |
| PQRIVLQGDNRSYSQ | 586 | A0A0J9YY54 | |
| SQGVSLYIPQATINA | 31 | A8MXK1 | |
| NAQGPLYEQRSTQTR | 586 | Q14157 | |
| YQVSAQGIQSTPLNL | 676 | Q9BQI5 | |
| GNILQIQGSQLSASY | 91 | Q02086 | |
| SNGTVSSVQYQVIPQ | 161 | Q02447 | |
| YRVPGNNAVVSSLQE | 941 | Q9P227 | |
| PYNSQGQAIVERTNR | 736 | P10266 | |
| PYNSQGQAIVERTNR | 736 | P63133 | |
| TGNRIYNPNSQALEL | 2636 | Q9H5I5 | |
| RYTGTRPSNLANNTI | 336 | P22309 | |
| PYNSQGQAIVERTNR | 736 | Q9UQG0 | |
| SQTQSIYIPRGVNVS | 111 | P38606 | |
| QIYPISQANANQRSG | 841 | Q92620 | |
| VANVPLTYQAEGSRQ | 1361 | Q70Z35 | |
| RQRNLSGSTLYPVSN | 1076 | Q2KHR2 | |
| ADGINITLSNPLNYT | 2351 | Q86WI1 | |
| GLYQAQVNLRTSQIS | 106 | Q96A28 | |
| IYRNPQNSSQSADGL | 51 | Q01081 | |
| LYRNPQNTAQTADGS | 51 | Q8WU68 | |
| QYPQQSLEQIGTRIA | 991 | Q96AE7 | |
| AQVTQNPRYLITVTG | 21 | A0A0K0K1C4 | |
| NYGTQLNAVNNSLTP | 186 | P10646 | |
| NYRNLVSLGVAISNP | 36 | Q15928 | |
| NINGTSYPSLQQKTN | 121 | Q8NB50 | |
| ISCRPQTQISNNYGN | 196 | Q8N823 | |
| SNKFQGVETPSQNRY | 361 | Q6XPS3 | |
| YTGTRPSNLANNTIL | 336 | P19224 | |
| NYSGDQGQTIRQLIS | 1876 | Q5T4S7 | |
| SNRSLAEGNLLYQPQ | 51 | Q9H9H4 | |
| SAAAQQYIRQGSPTA | 241 | Q8N5T2 | |
| YANNLTQLDNGVRIP | 191 | Q92995 | |
| LYASSQLNRPNSLVG | 791 | O14974 | |
| QLNRPNSLVGITSAY | 796 | O14974 |